247 related articles for article (PubMed ID: 24737911)
1. Early increase of abdominal adiposity in patients with spondyloarthritis receiving anti-tumor necrosis factor-α treatment.
Hmamouchi I; Roux C; Paternotte S; Kolta S; Dougados M; Briot K
J Rheumatol; 2014 Jun; 41(6):1112-7. PubMed ID: 24737911
[TBL] [Abstract][Full Text] [Related]
2. Increase in bone density in patients with spondyloarthritis during anti-tumor necrosis factor therapy: 6-year followup study.
Durnez A; Paternotte S; Fechtenbaum J; Landewé RB; Dougados M; Roux C; Briot K
J Rheumatol; 2013 Oct; 40(10):1712-8. PubMed ID: 23950191
[TBL] [Abstract][Full Text] [Related]
3. Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment.
Briot K; Gossec L; Kolta S; Dougados M; Roux C
J Rheumatol; 2008 May; 35(5):855-61. PubMed ID: 18381782
[TBL] [Abstract][Full Text] [Related]
4. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor inhibition and adipose tissue distribution -- are reported changes relevant to cardiometabolic risk?
Sheane BJ
J Rheumatol; 2014 Jun; 41(6):1035-7. PubMed ID: 24882846
[No Abstract] [Full Text] [Related]
6. Biological drug treatment of rheumatoid arthritis and spondyloarthritis: effects on QT interval and QT dispersion.
DI Franco M; Paradiso M; Ceccarelli F; Scrivo R; Spinelli FR; Iannuccelli C; Valesini G
J Rheumatol; 2012 Jan; 39(1):41-5. PubMed ID: 22045840
[TBL] [Abstract][Full Text] [Related]
7. Body weight, gender and response to TNF-α blockers in axial spondyloarthritis.
Gremese E; Bernardi S; Bonazza S; Nowik M; Peluso G; Massara A; Tolusso B; Messuti L; Miceli MC; Zoli A; Trotta F; Govoni M; Ferraccioli G
Rheumatology (Oxford); 2014 May; 53(5):875-81. PubMed ID: 24407233
[TBL] [Abstract][Full Text] [Related]
8. Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents.
Gao X; Wendling D; Botteman MF; Carter JA; Rao S; Cifaldi M
J Med Econ; 2012; 15(6):1054-63. PubMed ID: 22563743
[TBL] [Abstract][Full Text] [Related]
9. Effects of TNF antagonists on sperm characteristics in patients with spondyloarthritis.
Villiger PM; Caliezi G; Cottin V; Förger F; Senn A; Østensen M
Ann Rheum Dis; 2010 Oct; 69(10):1842-4. PubMed ID: 20610443
[TBL] [Abstract][Full Text] [Related]
10. Canadian Rheumatology Association Consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis.
Maksymowych WP; Inman RD; Gladman D; Thomson G; Stone M; Karsh J; Russell AS;
J Rheumatol; 2003 Jun; 30(6):1356-63. PubMed ID: 12784417
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study.
Gisondi P; Cotena C; Tessari G; Girolomoni G
J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):341-4. PubMed ID: 18005022
[TBL] [Abstract][Full Text] [Related]
12. Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis.
Finckh A; Simard JF; Gabay C; Guerne PA;
Ann Rheum Dis; 2006 Jun; 65(6):746-52. PubMed ID: 16339288
[TBL] [Abstract][Full Text] [Related]
13. The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study.
Lie E; Kristensen LE; Forsblad-d'Elia H; Zverkova-Sandström T; Askling J; Jacobsson LT;
Ann Rheum Dis; 2015 Jun; 74(6):970-8. PubMed ID: 25710471
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondyloarthritis.
Hugle B; Burgos-Vargas R; Inman RD; O'Shea F; Laxer RM; Stimec J; Whitney-Mahoney K; Duvnjak M; Anderson M; Tse SM
Clin Exp Rheumatol; 2014; 32(3):424-31. PubMed ID: 24387974
[TBL] [Abstract][Full Text] [Related]
15. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
[TBL] [Abstract][Full Text] [Related]
16. No significant changes in arterial stiffness in patients with ankylosing spondylitis after tumour necrosis factor alpha blockade treatment for 6 and 12 months.
Mathieu S; Pereira B; Couderc M; Rabois E; Dubost JJ; Soubrier M
Rheumatology (Oxford); 2013 Jan; 52(1):204-9. PubMed ID: 23065359
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.
Ciurea A; Scherer A; Exer P; Bernhard J; Dudler J; Beyeler B; Kissling R; Stekhoven D; Rufibach K; Tamborrini G; Weiss B; Müller R; Nissen MJ; Michel BA; van der Heijde D; Dougados M; Boonen A; Weber U;
Arthritis Rheum; 2013 Dec; 65(12):3096-106. PubMed ID: 23983141
[TBL] [Abstract][Full Text] [Related]
18. A randomised, multicentre, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trial.
Dougados M; Combe B; Braun J; Landewé R; Sibilia J; Cantagrel A; Feydy A; van der Heijde D; Leblanc V; Logeart I
Ann Rheum Dis; 2010 Aug; 69(8):1430-5. PubMed ID: 20511606
[TBL] [Abstract][Full Text] [Related]
19. CT-derived abdominal adiposity: Distributions and better predictive ability than BMI in a nationwide study of 59,429 adults in China.
Zeng Q; Wang L; Dong S; Zha X; Ran L; Li Y; Chen S; Gao J; Li S; Lu Y; Zhang Y; Xiao X; Li Y; Ma X; Gong X; Chen W; Yang Y; Du X; Chen B; Lv Y; Wu Y; Hong G; Pan Y; Jiao J; Yan Y; Qi H; Zhai J; Li K; Zhao K; Wu J; Liu S; Blake GM; Fu H; Fu X; Guo Z; Lemieux I; Després JP; Cheng X;
Metabolism; 2021 Feb; 115():154456. PubMed ID: 33259834
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of tumor necrosis factor α blockers in early axial spondyloarthritis: data from the DESIR cohort.
Moltó A; Paternotte S; Claudepierre P; Breban M; Dougados M
Arthritis Rheumatol; 2014 Jul; 66(7):1734-44. PubMed ID: 24623678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
